Clinical Trials Logo

Amblyopia clinical trials

View clinical trials related to Amblyopia.

Filter by:

NCT ID: NCT04482387 Recruiting - Visual Impairment Clinical Trials

DigiVis: Self-testing Vision App for Telephone Consultations

Start date: July 24, 2020
Phase: N/A
Study type: Interventional

This trial aims to assess the accuracy and test-retest variability of a new digital app which enables community visual acuity testing without requirement of an trained examiner.

NCT ID: NCT04432181 Completed - Amblyopia Clinical Trials

Comparison of Deviation Types Among Astigmatic Children With Or Without Amblyopia

Start date: September 4, 2018
Phase:
Study type: Observational [Patient Registry]

the records of astigmatic children were reviewed and any deviation was investigated at near and distance. refractive errors, stereopsis, convergence insufficiency were also evaluated. children were divided into two groups according to the presence of amblyopia and ocular deviations and other parameters were compared between groups.

NCT ID: NCT04429659 Completed - Refractive Errors Clinical Trials

Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia

Start date: January 2, 2019
Phase:
Study type: Observational

To investigate changes in refractive errors and evaluate clinical outcomes of strabismus surgery in patients with both amblyopia and partially refractive esotropia (PAET).Amblyopic patients with PAET were enrolled. Non-amblyopic patients with full refractive accommodative esotropia (RAET) were included in the study as a control group. Preoperative and postoperative best corrected visual acuity (BCVA), spherical equivalent (SE), astigmatism, stereoacuity and deviations at near and distance were evaluated and statistically compared in the patient group. The mean BCVA, SE, astigmatism were compared between the patient and the control groups.

NCT ID: NCT04378790 Recruiting - Amblyopia Clinical Trials

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

ATS22
Start date: December 8, 2020
Phase: N/A
Study type: Interventional

A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to <13 years of age.

NCT ID: NCT04321538 Completed - Amblyopia Clinical Trials

Gocheck Kids vs. Welch Allyn Spot Vision Screener

Start date: February 1, 2021
Phase:
Study type: Observational

The investigators are conducting a prospective evaluation of the ability of two vision photoscreening devices (GoCheck Kids and the Welch Allyn Spot Vision Screener) to detect risk factors for amblyopia. Photoscreeners function similar to having a picture taken with a camera. Amblyopia is decreased vision in one or both eyes due to decreased vision development in the brain resulting from decreased visual stimulation. Children ages 1 year to less than 7 years of age referred to a pediatric ophthalmologist at Yale New Haven Health and Yale Medicine locations for a failed vision screen will be offered participation. The ability of each screening device to detect amblyopia risk factors will be compared with the results of a complete eye exam performed by the practitioner.

NCT ID: NCT04315649 Completed - Amblyopia Clinical Trials

Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops

Start date: September 16, 2021
Phase: N/A
Study type: Interventional

This study evaluates the effect of 3D movie viewing on stereopsis recovery in anisometropic and / or strabismus amblyopia and the satisfaction with the intervention.

NCT ID: NCT04313257 Completed - Amblyopia Clinical Trials

Monocular Action Video Game Treatment of Amblyopia

Start date: September 17, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments.

NCT ID: NCT04310241 Recruiting - Amblyopia Clinical Trials

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Start date: February 21, 2020
Phase:
Study type: Observational

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.

NCT ID: NCT04303832 Completed - Amblyopia Clinical Trials

Exercise Interventions of Eye Muscles Post Strabismus Surgery

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

It will be hypothesized that: - Eye exercises have a positive effect on correction of remaining ocular deviation post strabismus surgery. - Eye exercises have a positive effect on improving amplyobia.

NCT ID: NCT04302701 Not yet recruiting - Amblyopia Clinical Trials

Dichoptic Treatment vs. Patching for Moderate Anisometropic Amblyopia

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Recently, there has been an increased interest in evaluating binocular therapies (e.g perceptual learning and dichoptic treatment) for amblyopia. They are designed to improve amblyopia through binocular stimulation by unlocking binocular visual function. The objective of the study is to compare the visual and sensory outcome of 2-hour patching to dichoptic stimulation using virtual reality head mounted display in the management of patients with moderate anisometropic amblyopia. The investigators will include children older than 6 years and adults up to the age of thirty five years with anisometropic amblyopia who either had no prior treatment for amblyopia or had prior treatment for amblyopia using patching therapy but with residual amblyopia defined as >= 0.3 logMAR lines between the best-corrected visual acuity in the sound eye and in the amblyopic eye and with moderate amblyopia in the more anisometropic eye defined as best-corrected visual acuity better than 6/60 but =< 6/18. Patients will be randomized into 2 groups according to age using stratified randomization: - Group P: (Patching Group): This group will have 2 hours of patching each day for 10 weeks. - Group D (Dichoptic Group): This group will have 1 hour of dichoptic stimulation using the virtual reality system twice a week for 10 weeks for a total of 20 hours of training.